Today's News |
|
Canadian Biotech Venture Capital Firm Lumira Starts Hedge Fund to Target Oversold Public Companies
Monday, September 19, 2022
Lumira has previously raised four venture capital funds to invest in private health sciences companies - including its latest, a US$223-million fund last year that was the largest in Canada in two decades - and backed some of the top Canadian names in the sector, including BC companies Aurinia Pharmaceuticals Inc. and Zymeworks Inc.
|
Share |
|||
|
Member Toolbar |
Globe and Mail Posted: Sep 19, 2022 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|